MedPath

Influence of reduction of standard preoperative fasting time and that added with protein in patients with head and neck cancer

Not Applicable
Recruiting
Conditions
Postoperative complications
Insulin resistance
Malignant neoplasm of head, face and neck
Head and Neck Neoplasms.
C76.0
C18.452.394.968.500
C23.550.767
C04.588.443
Registration Number
RBR-63ctjw
Lead Sponsor
Instituto Nacional de Câncer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

All patients who are candidates for elective surgeries; who are 19 years of age or older; and consent to participate in the study through the signing of the Informed Consent Form.

Exclusion Criteria

Volunteers inability to receive oral feeding in the preoperative period; without adherence to any of the phases of the study protocol; in use of prophylactic antiemetics 24 hours before surgery and in the immediate postoperative period; with previous diagnosis of diabetes mellitus, chronic kidney disease and / or liver disease, obesity (WHO, 2000); with presence of gastroesophageal reflux; intestinal obstruction and cases of gastroparesis and / or pyloric stenosis and surgeries with low nutritional impact (base of skull, maxillary sinuses, thyroid gland, parotid glands, cutaneous and ocular).

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increased muscle strength in the group receiving CHO-P, compared to the CHO group, around 10% higher, verified by assessment of palmar grip strength.
Secondary Outcome Measures
NameTimeMethod
Expected outcome 1: Reduction in response to insulin resistance, measured by the HOMA-IR and QUICKI indices, more effective in the CHO-P group with a difference of p <0.05 in relation to the CHO group.<br><br>Expected outcome 2: Lower incidence of postoperative complications, assessed by self-collected data sheet, in the CHO-P group compared to the CHO group. There is no expected reduction parameter.
© Copyright 2025. All Rights Reserved by MedPath